<html>
<head>PUBMED IDs for LUCA-1</head>
<body bgcolor='#C5F0F2'><h1>LUCA-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10508479/'>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</a> October 3  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10702795/'>HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA.</a> March 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10949932/'>LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis.</a> August 19  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11420683/'>LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells.</a> June 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12207175/'>Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways.</a> September 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12581154/'>Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5.</a> February 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12920317/'>RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle?</a> August 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15192330/'>LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals.</a> June 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15338470/'>Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis.</a> September 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16546166/'>Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes.</a> March 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16927403/'>The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein.</a> August 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16927391/'>Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3--&gt;q31.3) associated with Gorlin syndrome.</a> August 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17195868/'>The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.</a> January 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18840686/'>Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.</a> October 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19559772/'>Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23017209/'>RBM5 promotes exon 4 skipping of AID pre-mRNA by competing with the binding of U2AF65 to the polypyrimidine tract.</a> January 4  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23017199/'>Characterization of Mycobacterium orygis.</a> February 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23017188/'>Identification of the CFTR p.Phe508Del founder mutation in the absence of a polythymidine 9T allele in a Hispanic patient.</a> December 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23017167/'>Quantitative biomedical annotation using medical subject heading over-representation profiles (MeSHOPs).</a> May 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23017148/'>Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.</a> May 25  2012<br></body></html>
